Halstead Michael

CIK 00015215482 companiesROCKAWAY, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001521548

Recent Transactions

50 trades

Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−13,134→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02−12,240→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−45,454→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Common Stock
2025-04-02$132.00/sh−21,307→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−40,472→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−13,133→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2025-04-02−17,916→ 0 total
Disposition to Issuer
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-04-02−24,478→ 0 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+13,134→ 13,134 total
Award
Intra-Cellular Therapies, Inc.
Performance Stock Units
2025-04-02+12,240→ 12,240 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-10−7,345→ 0 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10$131.24/sh−3,757→ 21,307 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-10+7,345→ 25,064 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06$131.19/sh−6,718→ 17,719 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-06+13,133→ 24,437 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-06−13,133→ 13,133 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01$128.20/sh−6,261→ 11,304 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2025-03-01+12,239→ 17,565 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-03-01−12,239→ 24,478 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2025-02-03+45,454→ 45,454 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31+11,017→ 11,017 total
Tax Payment
Intra-Cellular Therapies, Inc.
Common Stock
2025-01-31$127.00/sh−5,691→ 5,326 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-13$36.89/sh+18,714→ 18,714 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-11-13−18,714→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-13$88.92/sh−5,343→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-13$88.17/sh−13,371→ 5,343 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-12$90.89/sh−1,648→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-12$23.94/sh+22,869→ 22,869 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-12$89.63/sh−6,116→ 1,648 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-11-12$88.72/sh−15,105→ 7,764 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Stock Option (right to buy)
2024-11-12−22,869→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$66.70/sh−1,238→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-11$65.82/sh−6,107→ 1,238 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-10+7,345→ 7,345 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-10−7,345→ 7,345 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.14/sh−12,912→ 220 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-07$66.81/sh−220→ 0 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-06−13,132→ 26,266 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-03-06+13,132→ 13,132 total
Award
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-03-01+36,717→ 36,717 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$70.13/sh−392→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$68.54/sh−300→ 7,607 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-26$69.54/sh−7,215→ 392 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-23+7,907→ 7,907 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Restricted Stock Units
2024-02-23−7,907→ 0 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$66.37/sh−11,146→ 714 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-02$67.17/sh−714→ 0 total
Award
Intra-Cellular Therapies, Inc.
Common Stock
2024-02-01+11,860→ 11,860 total
Exercise/Conversion
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-11$12.73/sh+46,115→ 46,115 total
Sale
Intra-Cellular Therapies, Inc.
Common Stock
2024-01-11$66.31/sh−18,154→ 31,846 total

Companies

Recent Filings

Address

C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE

ROCKAWAY, NJ, 07866

View on SEC.gov